IPG

IPG Announces Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Thursday, February 8, 2024
Travel, Share repurchase, AI, Employment, Appendix, Depreciation, IPG, Software, Health, Pharmaceutical industry

Adjusted EBITA before restructuring charges was $628.5 million in the fourth quarter of 2023, compared to $568.4 million for the same period in 2022.

Key Points: 
  • Adjusted EBITA before restructuring charges was $628.5 million in the fourth quarter of 2023, compared to $568.4 million for the same period in 2022.
  • Revenue before billable expenses was $2.59 billion in the fourth quarter of 2023 compared to $2.55 billion in the fourth quarter of 2022.
  • Depreciation and amortization expense decreased by 9.4% during the fourth quarter of 2023, and decreased by 3.5% for the full year 2023.
  • During the fourth quarter of 2023, the Company declared and paid a common stock cash dividend of $0.310 per share, for a total of $117.9 million.

Susan Credle to Become First-Ever IPG Creative Advisor

Retrieved on: 
Monday, February 5, 2024
Bank of America, Creativity, Growth, The One Club, FedEx, Adviser, Walmart, Commerce, AB, FCB, AAF, M&J, Marketing, Kimberly-Clark, AB InBev, IPG, Bank, Culture, BBDO, Anheuser-Busch brands, Woman, Creative industries

New York, NY, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Interpublic Group (NYSE: IPG) announced today the appointment of Susan Credle as its first-ever Creative Advisor.

Key Points: 
  • New York, NY, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Interpublic Group (NYSE: IPG) announced today the appointment of Susan Credle as its first-ever Creative Advisor.
  • In the new role, partnering with creative leaders across IPG’s agencies, Susan will advance the culture of creativity at IPG, ensuring it is central in all the network’s work for brands.
  • Susan will continue to be a leading creative champion for the industry and assist IPG agencies in attracting and nurturing global creative talent.
  • In the role, Susan will consult with IPG companies on their unique creative frameworks, advise on IPG’s global production solution, and bring a creative lens to IPG’s central leadership team.

Huge Launches Culture Decoder, a Comprehensive Tool for Analyzing Cultural Data

Retrieved on: 
Monday, February 5, 2024
Momentum, Growth, Culture, Analyst, Decoder, Love, IPG, Insurance, Conditional

By analyzing billions of data points, the proprietary tool assesses trend relevance for target customer groups; calculates the size, sentiment, and momentum of each trend; and provides actionable and data-driven recommendations to help brands drive engagement.

Key Points: 
  • By analyzing billions of data points, the proprietary tool assesses trend relevance for target customer groups; calculates the size, sentiment, and momentum of each trend; and provides actionable and data-driven recommendations to help brands drive engagement.
  • The tool also provides users with the context and reasons trends matter within an industry, as well as the relationship seen between them.
  • “But too often they use the same list of banal customer data categories to get equally banal business results.
  • Culture Decoder can offer them the fully comprehensive insights they need to make more timely, informed decisions that drive loyalty and growth.

Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

Retrieved on: 
Thursday, February 1, 2024
Cancer, Neoplasm, Genetics, RNA, LCD, DNA, Patient, Intermountain Health, Genetic testing, MYGN, Medicine, Acquisition, IPG, Medicare, Medical imaging

SALT LAKE CITY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it has completed the acquisition from Intermountain Health of select assets from its Intermountain Precision Genomics (IPG) laboratory business, including the Precise™ Tumor Test, the Precise Liquid Test, and IPG’s CLIA-certified laboratory in St. George, Utah.

Key Points: 
  • SALT LAKE CITY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it has completed the acquisition from Intermountain Health of select assets from its Intermountain Precision Genomics (IPG) laboratory business, including the Precise™ Tumor Test, the Precise Liquid Test, and IPG’s CLIA-certified laboratory in St. George, Utah.
  • Myriad’s Precise Tumor Test, which was also offered by IPG as TheraMap®: Solid Tumor, analyzes a patient’s tumor DNA to discover and target important variants within tumors.
  • Myriad will operate TheraMap: Solid Tumor solely as Precise Tumor moving forward.
  • Precise Liquid, which is expected to launch later this year, will provide convenient comprehensive genomic profiling results from a blood draw.

Danny Robinson Named CEO of The Martin Agency

Retrieved on: 
Tuesday, January 30, 2024
The Martin Agency, Growth, Life, Martin, DEI, Social media, UPS, CCO, MullenLowe Group, Creativity, IPG, NYFW, AAAA, Film industry

New York, NY, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Interpublic Group (NYSE: IPG) announced today that Danny Robinson has been named CEO of The Martin Agency.

Key Points: 
  • New York, NY, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Interpublic Group (NYSE: IPG) announced today that Danny Robinson has been named CEO of The Martin Agency.
  • He’ll be taking on the leadership responsibilities from Kristen Cavallo, who has led The Martin Agency for the past six years and was named Global CEO of sister agency MullenLowe Group fourteen months ago.
  • An industry veteran, Robinson has been with The Martin Agency for nearly two decades, serving most recently as its Chief Creative Officer.
  • During his time at Martin, Robinson has helped lead the agency in its mission to fight against invisibility, infusing that idea throughout the creative output.

IPG Presents New Technologies, Products and Solutions for E-mobility Manufacturing, Materials Processing and Specialized Applications at Photonics West 2024

Retrieved on: 
Monday, January 29, 2024
CO2, Laser, UV, Convection, IPGP, Research, Ultraviolet, Heat, Electronics, AMB, Computer, Specialization, Software, Welding, MES, EV, SPIE, IPG, LDD

MARLBOROUGH, Mass., Jan. 29, 2024 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ: IPGP) will highlight new and innovative fiber laser solutions at Photonics West January 30 – February 01, 2024 in San Francisco.

Key Points: 
  • MARLBOROUGH, Mass., Jan. 29, 2024 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ: IPGP) will highlight new and innovative fiber laser solutions at Photonics West January 30 – February 01, 2024 in San Francisco.
  • Manufacturers benefit from high-efficiency heating solutions which provide dramatically faster heating and drying processes with minimal waste heat.
  • For high-power materials processing, new ECO series high-efficiency laser sources, provide unmatched high-power reliability with over 50% energy efficiency.
  • IPG software provides powerful features in a simple and intuitive user interface for remote processing applications including cutting, welding, cleaning and marking.

IPG Names Lisa De Bonis CEO of Huge

Retrieved on: 
Tuesday, January 23, 2024
Work Club, SABMiller, De Bonis, AI, Havas, Creativity, Organization, IPG, Growth

New York, NY, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Interpublic Group (NYSE: IPG) announced today that Lisa De Bonis has been named the new CEO of creative consultancy Huge.

Key Points: 
  • New York, NY, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Interpublic Group (NYSE: IPG) announced today that Lisa De Bonis has been named the new CEO of creative consultancy Huge.
  • “Huge sits at the intersection of technology and creativity, building digital products that drive growth and transformation for marketers.
  • Prior to Huge, De Bonis served as Managing Director at Accenture Interactive, operating in multiple leadership roles across the UK and Europe.
  • Over the last year Huge has launched results-based work for some of the world’s most courageous brands, including M&M’S, McDonald’s, Google, and more.

Momentum Worldwide Secures Milestone Sponsorship for Chevrolet Across Major League Soccer in Canada

Retrieved on: 
Monday, January 22, 2024
Momentum, Major League Soccer, Partnership, FC, PR, CF Montréal, Montreal Impact, Carat, MLS, IPG, Vancouver Whitecaps FC, Football, Growth

New York, NY, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Momentum Worldwide, a global sponsorship and experience marketing agency that is part of Interpublic Group (NYSE: IPG), has led strategic negotiations and secured an exclusive partnership on behalf of Chevrolet and Major League Soccer (MLS) in Canada.

Key Points: 
  • New York, NY, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Momentum Worldwide, a global sponsorship and experience marketing agency that is part of Interpublic Group (NYSE: IPG), has led strategic negotiations and secured an exclusive partnership on behalf of Chevrolet and Major League Soccer (MLS) in Canada.
  • With the agreement now signed, soccer fans can look forward to new initiatives and unique experiences from Chevrolet.
  • "Chevrolet Canada is excited to partner with MLS, Vancouver Whitecaps, Toronto FC, and CF Montreal to support the highest level of soccer in Canada," said James Hodge, Brand Director of Chevrolet Canada.
  • The announcement of the partnership between MLS in Canada and Chevrolet comes at a time of tremendous momentum, growth, and investment in the sport of soccer in North America.

Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

Retrieved on: 
Thursday, January 18, 2024
Neoplasm, LCD, Myriad Genetics, Patient, Intermountain, DNA, Medicare, RNA, Myriad, Genetics, Genetic testing, Acquisition, MYGN, Intermountain Health, IPG, Medicine, Growth, Pharmaceutical industry

SALT LAKE CITY, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it has entered into a definitive agreement to acquire select assets from Intermountain Precision Genomics’ (IPG) laboratory business, including the Precise™ Tumor Test, the Precise Liquid Test, and IPG’s CLIA-certified laboratory in St. George, Utah where the Precise Tumor Test is currently performed.

Key Points: 
  • SALT LAKE CITY, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it has entered into a definitive agreement to acquire select assets from Intermountain Precision Genomics’ (IPG) laboratory business, including the Precise™ Tumor Test, the Precise Liquid Test, and IPG’s CLIA-certified laboratory in St. George, Utah where the Precise Tumor Test is currently performed.
  • By bringing the Precise Tumor and Precise Liquid tests in house, Myriad will open up new opportunities for innovation, growth, and continued development of its oncology portfolio.
  • Upon the closing of the acquisition on February 1, 2024, Myriad expects to operate TheraMap: Solid Tumor solely as Precise Tumor.
  • The financial terms of the deal were not disclosed but are not material to either Myriad or Intermountain Healthcare.

 IPG Mediabrands Receives the ISO 27001:2013 Global Certification

Retrieved on: 
Monday, January 22, 2024
Security, Marketing, Communications, Media, Technology, ISO, Information, Privacy, Information technology, ISMS, Safety, IPG, Certification

IPG Mediabrands, the media holding company within Interpublic Group (NYSE: IPG) announced today it’s been awarded a Global ISO 27001:2013 certification for its quality information security management system (ISMS).

Key Points: 
  • IPG Mediabrands, the media holding company within Interpublic Group (NYSE: IPG) announced today it’s been awarded a Global ISO 27001:2013 certification for its quality information security management system (ISMS).
  • IPG Mediabrands certification was issued by Schellman after undergoing an assessment and audit of the information systems and processes to ensure global compliance.
  • “At IPG Mediabrands, we are committed to building trust and instilling confidence among our leaders and clients that our safety and security practices far exceed industry standards,” said Frank Ribitch, Global Chief Information Officer, IPG Mediabrands.
  • Our commitment to upholding the ISO 27001 certification is not a one and done process, but rather, we strive to renew and uphold our certification each year,” said Myra Santos, SVP Cybersecurity Compliance Risk Officer at IPG Mediabrands.